[Possible effects of pharmacologic prophylaxis for Mendelson's syndrome on newborns].
Forty-eight newborn infants whose mothers underwent both elective and urgent caesarean section were studied. Mothers were randomly assigned to one of the treatment groups for the prophylaxis of Aspiration Pneumonitis: group A was treated with ranitidine, 50 mg i.v.; group B with ranitidine, 50 mg, and metoclopramide, 10 mg i.v.; group C no medication. Neonatal assessment included Apgar score and various haematological laboratory tests: haemogasanalysis, glycemia, electrolites, hematocrit, hemoglobin, bilirubinemia, SGOT, SGPT. Nor clinical or statistic differences were noted among the three infant groups.
Bifarini
G
G
Istituto di Anestesiologia e Rianimazione, Università degli Studi di Perugia.
Trabalza
N
N
Falconi
S
S
Malà
L
L
Favetta
P
P
D000704:Analysis of Variance; D001784:Blood Gas Analysis; D002585:Cesarean Section; D006801:Humans; D007231:Infant, Newborn; D008787:Metoclopramide / Q000627:therapeutic use*; D011015:Pneumonia, Aspiration / Q000097:blood / Q000517:prevention & control*; D011899:Ranitidine / Q000627:therapeutic use*; D013577:Syndrome
D011899:Ranitidine; D008787:Metoclopramide
Ricerca sul neonato di eventuali effetti della profilassi farmacologica della sindrome di Mendelson.